Acute Respiratory Failure: Lifespan Phenotypes and Trajectories

Acute respiratory failure (ARF) represents a critical challenge in intensive care, characterised by the inability of the respiratory system to maintain adequate gas exchange. While the clinical syndrome is broadly defined, its manifestations, progression, and optimal management differ considerably across the lifespan. Pediatric ARF, for instance, frequently arises from conditions such as bronchiolitis, pneumonia, and asthma exacerbations, often involving smaller airway diameters and higher airway resistance compared to adults.¹ The developing lung also exhibits distinct compliance characteristics and susceptibility to ventilator-induced lung injury (VILI).² In contrast, adult ARF is commonly associated with acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) exacerbations, and cardiogenic pulmonary oedema, often involving different inflammatory pathways and lung parenchymal changes.³

Physiological Differences and Phenotypes

The physiological distinctions between pediatric and adult respiratory systems dictate divergent ARF phenotypes. Children, particularly infants, possess a higher chest wall compliance and a more compliant diaphragm, which can lead to increased work of breathing and earlier respiratory muscle fatigue.¹ Their smaller functional residual capacity (FRC) and higher metabolic rate contribute to more rapid desaturation during apneic episodes.⁴ Furthermore, the immature immune system in children can result in different inflammatory responses to pathogens, influencing the severity and duration of ARF.⁵

Adult ARF, particularly ARDS, is often characterised by diffuse alveolar damage, increased pulmonary vascular permeability, and severe hypoxemia refractory to conventional oxygen therapy.³ Phenotypes within adult ARDS, such as hyperinflammatory versus hypoinflammatory, have been identified, influencing treatment response to corticosteroids and other immunomodulators.⁶ While similar inflammatory markers exist in pediatric ARDS (PARDS), their prognostic significance and response to targeted therapies may differ due to developmental variations in immune regulation.⁵

Ventilatory mechanics also present age-specific challenges. In pediatric ARF, maintaining appropriate tidal volumes and positive end-expiratory pressure (PEEP) is critical to prevent VILI, given the smaller lung volumes and increased susceptibility to barotrauma.² High-frequency oscillatory ventilation (HFOV) and non-invasive ventilation (NIV) are frequently employed in pediatric populations, with specific considerations for interface selection and pressure settings.⁷ Adult ARF management often focuses on lung-protective ventilation strategies, including low tidal volumes (6 mL/kg predicted body weight) and plateau pressure targets (<30 cm H₂O), as demonstrated in numerous trials.⁸ The application of these adult-derived strategies to pediatric patients requires careful adaptation, as direct extrapolation may not be appropriate.²

Pharmacological interventions also vary. Bronchodilators and corticosteroids are mainstays in pediatric ARF secondary to asthma or bronchiolitis.⁹ In adult ARDS, while corticosteroids have shown benefit in specific phenotypes, their widespread use remains debated.⁶ The pharmacokinetics and pharmacodynamics of sedatives, analgesics, and neuromuscular blockers also differ across age groups, necessitating age- and weight-adjusted dosing to avoid adverse effects.¹⁰

Trajectories and Long-Term Outcomes

The trajectories of recovery and long-term outcomes following ARF also exhibit age-related differences. Pediatric survivors of ARF, particularly those with PARDS, may experience long-term pulmonary impairment, neurocognitive deficits, and reduced quality of life.¹¹ The developing brain and lungs are particularly vulnerable to the sequelae of critical illness, including prolonged mechanical ventilation and systemic inflammation.¹² Follow-up studies indicate that a significant proportion of pediatric ARF survivors require ongoing respiratory support or experience exercise intolerance years after discharge.¹¹

Adult survivors of ARF, especially those with ARDS, frequently suffer from post-intensive care syndrome (PICS), encompassing physical, cognitive, and psychological impairments.¹³ Persistent muscle weakness, cognitive dysfunction (e.g., memory impairment, executive dysfunction), and mental health issues (e.g., depression, PTSD) are common.¹³ While some overlap exists, the specific patterns and severity of these long-term morbidities may differ, reflecting the distinct developmental stages and underlying comorbidities present in each population. Understanding these age-specific trajectories is crucial for developing targeted rehabilitation programs and long-term support strategies.